067630 Stock Chart & Stats
₩2465.00
-₩50.00(-1.99%)
―
--
Day’s Range― - ―
52-Week Range₩1,608.00 - ₩5,330.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)229.31K
Market Cap
₩306.45B
Enterprise Value₩547.93K
Total Cash (Recent Filing)₩13.88B
Total Debt (Recent Filing)₩160.36B
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-876.55
Shares Outstanding121,917,060
10 Day Avg. Volume144,570
30 Day Avg. Volume229,307
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)4.64
Price to Sales (P/S)30.16
P/FCF Ratio-28.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
067630 FAQ
What was HLB Life Science Co.,Ltd.’s price range in the past 12 months?
HLB Life Science Co.,Ltd. lowest stock price was ₩1608.00 and its highest was ₩5330.00 in the past 12 months.
What is HLB Life Science Co.,Ltd.’s market cap?
HLB Life Science Co.,Ltd.’s market cap is ₩306.45B.
When is HLB Life Science Co.,Ltd.’s upcoming earnings report date?
HLB Life Science Co.,Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 64 days.
How were HLB Life Science Co.,Ltd.’s earnings last quarter?
HLB Life Science Co.,Ltd. released its earnings results on Aug 07, 2026. The company reported -₩71.389 earnings per share for the quarter.
Is HLB Life Science Co.,Ltd. overvalued?
According to Wall Street analysts HLB Life Science Co.,Ltd.’s price is currently Undervalued.
Does HLB Life Science Co.,Ltd. pay dividends?
HLB Life Science Co.,Ltd. does not currently pay dividends.
What is HLB Life Science Co.,Ltd.’s EPS estimate?
HLB Life Science Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLB Life Science Co.,Ltd. have?
HLB Life Science Co.,Ltd. has 121,917,060 shares outstanding.
What happened to HLB Life Science Co.,Ltd.’s price movement after its last earnings report?
HLB Life Science Co.,Ltd. reported an EPS of -₩71.389 in its last earnings report. Following the earnings report the stock price went up 5.708%.
Which hedge fund is a major shareholder of HLB Life Science Co.,Ltd.?
Currently, no hedge funds are holding shares in KR:067630
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HLB Life Science Co.,Ltd.
HLB Life Science Co Ltd specializes in a range of energy solutions, encompassing both traditional services and renewable power initiatives. Its offerings include advanced energy-saving facilities, systems for recovering condensing water, combined heat and power (cogeneration) setups, and the development of solar energy projects. Complementing its established energy operations, the company has also diversified its investments into novel pharmaceutical development and the broader medical field.
Technical Analysis
HLB PHARMACEUTICAL CO., LTD.
―
Kolon Life Science Inc.
―
EuBiologics Co., Ltd.
―
SillaJen, Inc.
―
IMBiologics Corp.
―